Discontinuation report EPIRUBICIN FOR INJECTION

Last updated on 2020-10-24 History
Report ID 126906
Drug Identification Number 02324091
Brand name EPIRUBICIN FOR INJECTION
Common or Proper name EPIRUBICIN FOR INJECTION 2mg/ml
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPIRUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-10-23
Actual discontinuation date 2020-10-23
Remaining supply date 2020-10-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontinued as of Oct 23 2020
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-10-24 English Compare
v2 2020-10-22 French Compare
v1 2020-10-22 English Compare